Innovation Pharmaceuticals Inc (IPIX)

[Whoops]

Looks like Kevetrin is in lead. Nutlins are toxic the company has been searching for years to find an application where thats not true. The other phase1 I have not heard of. The big thing/challenge with reactivating p53 in my view is doing so without toxicity Kevetrin appears to have resounding success here. With signs of efficacy in ovarian, pancreatic and thyroma in phase 1 dose esculation study. I cannot wait to see wait to see what happens in these phase 2 studies with a optimized dosing. Kevetrin clears quickly out of the body increasing dosing frenquency will be interesting!

We also get to see K tackle blood cancers at optimized doses which is likely to occur before the phase 2 solid tumors.